Clinical Trial Update: Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of febuxostat on renal function in patients with gout and moderate to severe renal impairment; results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Gout

Drugs mentioned

• Uloric (febuxostat)

Snippet

Sponsor: Takeda | Conditions: Renal Impairment | Phase 2 | Status: COMPLETED | Results posted: 2013-09-25